{"id":"W2239698670","doi":"10.1016/s1470-2045(15)00518-5","title":"Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Sanofi; Amgen","keywords":"Enzalutamide; Bicalutamide; Prostate cancer; Medicine; Oncology; Internal medicine; Androgen receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007060251,0.0001866884,0.0008085999,0.00008199182,0.0001068431,0.000008198959,0.000132498,0.00004555884,0.00005799303],"category_scores_gemma":[0.0001401829,0.00007633577,0.00005608948,0.0001583314,0.0003973737,0.00005865935,0.00006230402,0.0001263471,0.000003111023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002093755,"about_ca_system_score_gemma":0.0003310414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006959252,"about_ca_topic_score_gemma":0.0001195126,"domain_scores_codex":[0.9984608,0.0002013811,0.0003384356,0.000306302,0.0002585702,0.0004344526],"domain_scores_gemma":[0.9978093,0.001335053,0.0001867314,0.00033,0.0002123269,0.0001266075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9280643,0.002237693,0.01349685,0.0001100214,0.001168594,0.0000199313,0.001760609,0.000002537795,0.0005082309,0.00004796207,0.0002585196,0.05232469],"study_design_scores_gemma":[0.9598843,0.0194211,0.01257433,0.0001243102,0.0008997969,0.000004163893,0.0002917243,0.00001301778,0.0007215855,0.0000538328,0.005891768,0.0001200667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859946,0.0004328025,0.00006225624,0.004718917,0.0001301973,0.008243828,0.0001737935,0.00002641331,0.0002172161],"genre_scores_gemma":[0.996784,0.0006106283,0.0002364895,0.0001205038,0.0001405216,0.001583917,0.00003172165,0.00002804294,0.0004642209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05220462,"threshold_uncertainty_score":0.3112882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09227178365285235,"score_gpt":0.4254760336601119,"score_spread":0.3332042500072595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}